Ensemble-based virtual screening of African natural products to target human thymidylate synthase.

[1]  Andrew S. Paluch,et al.  Targeting human thymidylate synthase: Ensemble-based virtual screening for drug repositioning and the role of water. , 2022, Journal of molecular graphics & modelling.

[2]  F. Ntie‐Kang,et al.  Finding alternatives to 5-fluorouracil: application of ensemble-based virtual screening for drug repositioning against human thymidylate synthase , 2022, Journal of biomolecular structure & dynamics.

[3]  H. Kalaji,et al.  Recent Advances in Alternaria Phytotoxins: A Review of Their Occurrence, Structure, Bioactivity, and Biosynthesis , 2022, Journal of fungi.

[4]  Carlos A. Brizuela,et al.  Improving Structure-Based Virtual Screening with Ensemble Docking and Machine Learning , 2021, J. Chem. Inf. Model..

[5]  Reed M. Stein,et al.  A practical guide to large-scale docking , 2021, Nature Protocols.

[6]  Diogo Santos-Martins,et al.  AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings , 2021, J. Chem. Inf. Model..

[7]  C. Kundu,et al.  5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  Kiran K. Telukunta,et al.  Pharmacoinformatic Investigation of Medicinal Plants from East Africa , 2020, Molecular informatics.

[9]  Maria Paola Costi,et al.  Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth , 2019, Molecules.

[10]  Luca Pinzi,et al.  Molecular Docking: Shifting Paradigms in Drug Discovery , 2019, International journal of molecular sciences.

[11]  K. Sasikala,et al.  Molecular Docking in Modern Drug Discovery: Principles and Recent Applications , 2019, Drug Discovery and Development - New Advances.

[12]  Maria Paola Costi,et al.  Structural Comparison of Enterococcus faecalis and Human Thymidylate Synthase Complexes with the Substrate dUMP and Its Analogue FdUMP Provides Hints about Enzyme Conformational Variabilities , 2019, Molecules.

[13]  Sheng-You Huang,et al.  Comprehensive assessment of flexible‐ligand docking algorithms: current effectiveness and challenges , 2018, Briefings Bioinform..

[14]  L. Dardenne,et al.  Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and Challenges , 2018, Front. Pharmacol..

[15]  N. Gautham,et al.  Protein–small molecule docking with receptor flexibility in iMOLSDOCK , 2018, Journal of Computer-Aided Molecular Design.

[16]  Athanasia Pavlopoulou,et al.  The challenge of drug resistance in cancer treatment: a current overview , 2018, Clinical & Experimental Metastasis.

[17]  Lamiaa N. Hammad,et al.  Biomolecular study of human thymidylate synthase conformer-selective inhibitors: New chemotherapeutic approach , 2018, PloS one.

[18]  Kiran K. Telukunta,et al.  NANPDB: A Resource for Natural Products from Northern African Sources. , 2017, Journal of natural products.

[19]  P. Nordlund,et al.  Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states , 2017, The Journal of Biological Chemistry.

[20]  John A. Keith,et al.  A sobering assessment of small-molecule force field methods for low energy conformer predictions , 2017, 1705.04308.

[21]  William L. Jorgensen,et al.  LigParGen web server: an automatic OPLS-AA parameter generator for organic ligands , 2017, Nucleic Acids Res..

[22]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[23]  Shuai Ji,et al.  Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra. , 2017, Journal of natural products.

[24]  J. Tuszynski,et al.  Software for molecular docking: a review , 2017, Biophysical Reviews.

[25]  Ruth Huey,et al.  Computational protein–ligand docking and virtual drug screening with the AutoDock suite , 2016, Nature Protocols.

[26]  S. Faeth,et al.  Altertoxins with potent anti-HIV activity from Alternaria tenuissima QUE1Se, a fungal endophyte of Quercus emoryi. , 2014, Bioorganic & medicinal chemistry.

[27]  Rajendra Kumar,et al.  g_mmpbsa - A GROMACS Tool for High-Throughput MM-PBSA Calculations , 2014, J. Chem. Inf. Model..

[28]  Wolfgang Sippl,et al.  AfroDb: A Select Highly Potent and Diverse Natural Product Library from African Medicinal Plants , 2013, PloS one.

[29]  Ligang Zhou,et al.  Metabolites from Alternaria Fungi and Their Bioactivities , 2013, Molecules.

[30]  A. Giglio,et al.  Tegafur–uracil is a safe alternative for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle , 2012, Therapeutic advances in medical oncology.

[31]  Stefano Forli,et al.  A force field with discrete displaceable waters and desolvation entropy for hydrated ligand docking. , 2012, Journal of medicinal chemistry.

[32]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[33]  Rebecca C Wade,et al.  The active–inactive transition of human thymidylate synthase: Targeted molecular dynamics simulations , 2011, Proteins.

[34]  Maria Paola Costi,et al.  Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase , 2011, Proceedings of the National Academy of Sciences.

[35]  Roland L. Dunbrack,et al.  A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions. , 2011, Structure.

[36]  J. Chapman,et al.  Abstract 1348: The discovery of novel inhibitors that downregulate human thymidylate synthase , 2011 .

[37]  Wolfgang Wenzel,et al.  Receptor flexibility in small‐molecule docking calculations , 2011 .

[38]  R. Bergan,et al.  Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression. , 2010, ACS medicinal chemistry letters.

[39]  Xiaoqin Zou,et al.  Advances and Challenges in Protein-Ligand Docking , 2010, International journal of molecular sciences.

[40]  V. Chandregowda,et al.  Synthesis of (+/-)Abyssinone I and related compounds: Their anti-oxidant and cytotoxic activities. , 2009, European journal of medicinal chemistry.

[41]  Tjelvar S. G. Olsson,et al.  The thermodynamics of protein-ligand interaction and solvation: insights for ligand design. , 2008, Journal of molecular biology.

[42]  R. Abagyan,et al.  Flexible ligand docking to multiple receptor conformations: a practical alternative. , 2008, Current opinion in structural biology.

[43]  Rommie E. Amaro,et al.  An improved relaxed complex scheme for receptor flexibility in computer-aided drug design , 2008, J. Comput. Aided Mol. Des..

[44]  L. Lebioda,et al.  Cooperative inhibition of human thymidylate synthase by mixtures of active site binding and allosteric inhibitors. , 2007, Biochemistry.

[45]  M. Parrinello,et al.  Canonical sampling through velocity rescaling. , 2007, The Journal of chemical physics.

[46]  Xin Wen,et al.  BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..

[47]  Roland L. Dunbrack,et al.  Statistical and conformational analysis of the electron density of protein side chains , 2006, Proteins.

[48]  Ajay N. Jain,et al.  Scoring functions for protein-ligand docking. , 2006, Current protein & peptide science.

[49]  Bengt Nordén,et al.  Scope and Limitation of Ligand Docking: Methods, Scoring Functions and Protein Targets , 2005 .

[50]  L. Lebioda,et al.  Structure of human thymidylate synthase under low-salt conditions. , 2005, Acta crystallographica. Section D, Biological crystallography.

[51]  Natasja Brooijmans,et al.  Molecular recognition and docking algorithms. , 2003, Annual review of biophysics and biomolecular structure.

[52]  J. Gertsch,et al.  Cytotoxic versus anti-inflammatory effects in HeLa, Jurkat T and human peripheral blood cells caused by guaianolide-type sesquiterpene lactones. , 2003, Bioorganic & medicinal chemistry.

[53]  A. Brigo,et al.  The Poisson–Boltzmann equation for biomolecular electrostatics: a tool for structural biology , 2002, Journal of molecular recognition : JMR.

[54]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[55]  L. Lebioda,et al.  Human thymidylate synthase is in the closed conformation when complexed with dUMP and raltitrexed, an antifolate drug. , 2001, Biochemistry.

[56]  F. Maley,et al.  Probing the Folate-binding Site of Human Thymidylate Synthase by Site-directed Mutagenesis , 1998, The Journal of Biological Chemistry.

[57]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..

[58]  Thomas A. Halgren,et al.  Merck molecular force field. V. Extension of MMFF94 using experimental data, additional computational data, and empirical rules , 1996, J. Comput. Chem..

[59]  T. Halgren.  Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions , 1996 .

[60]  T. Halgren.  Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..

[61]  P. Johnston,et al.  Thymidylate synthase and drug resistance. , 1995, European journal of cancer.

[62]  M. Taniguchi,et al.  Ethnobotanical drug discovery based on medicine men's trials in the African savanna: screening of east African plants for antimicrobial activity II. , 1993, Journal of natural products.

[63]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[64]  T. Straatsma,et al.  THE MISSING TERM IN EFFECTIVE PAIR POTENTIALS , 1987 .

[65]  P. Kollman,et al.  An approach to computing electrostatic charges for molecules , 1984 .

[66]  M. Parrinello,et al.  Polymorphic transitions in single crystals: A new molecular dynamics method , 1981 .

[67]  David S. Goodsell,et al.  Automated Docking of Flexible Ligands to Flexible Receptors , 2010 .